Skip to main content
TipRanks
Go Ultimate75% OFF

Laboratorios Farmaceuticos Rovi (41L) Q2 2025 Earnings Report

4 Followers

DE:41L Q2 2025 EPS Results

Actual EPS
EUR 0.42
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.86

DE:41L Q2 2025 Revenue Results

Actual Revenue
EUR 159.70M
Expected Revenue
EUR 158.98M
Beat/Miss
Beat by +EUR 715.00K
YoY Revenue Growth
-10.36%

Earnings Announcement Details

Quarter
Q2 2025
Date
07/24/2025
Time
TBA
Conference Call
Thursday, July 24, 2025
DE:41L Upcoming Earnings

Laboratorios Farmaceuticos Rovi's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:41L Earnings History

DE:41L earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)―-0.83――
Nov 05, 20262026 (Q3)―1.531.1335.19% (+0.40)
Jul 23, 20262026 (Q2)―1.470.42246.57% (+1.04)
May 06, 20262026 (Q1)―0.180.35-47.74% (-0.17)
Feb 25, 20262025 (Q4)―0.830.4682.49% (+0.38)
Nov 06, 20252025 (Q3)―1.130.8631.86% (+0.27)
Jul 24, 20252025 (Q2)―0.420.86-50.81% (-0.44)
May 08, 20252025 (Q1)―0.350.2922.49% (+0.07)
Feb 25, 20252024 (Q4)―0.460.99-54.02% (-0.54)
Nov 07, 20242024 (Q3)―1.360.9839.47% (+0.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed